Eric Mark Green, President & CEO at WEST PHARMACEUTICAL SERVICES INC (WST), sold 86,900 shares at $239.70 ($20.8M) on 2022-12-05, disclosed to the SEC on 2022-12-08.
Open-market sale of $20.8M WST by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.95 | 6,746 | $1.6M | 7.7% |
| 2 | $236.95 | 6,746 | $1.6M | 7.7% |
| 3 | $237.67 | 9,408 | $2.2M | 10.8% |
| 4 | $237.67 | 9,408 | $2.2M | 10.8% |
| 5 | $238.83 | 6,312 | $1.5M | 7.3% |
| 6 | $238.83 | 6,312 |
| $1.5M |
| 7.3% |
| 7 | $239.70 | 10,752 | $2.6M | 12.4% |
| 8 | $239.70 | 10,752 | $2.6M | 12.4% |
| 9 | $240.73 | 9,682 | $2.3M | 11.2% |
| 10 | $240.73 | 9,682 | $2.3M | 11.2% |
| 11 | $241.46 | 1,100 | $266K | 1.3% |
| Total | $238.96 avg | 86,900 | $20.8M | 100% |
| Filing → |
| WST | SELL | 2024-05-09 | $48.4M | — | Filing → |
| WST | SELL | 2024-02-29 | $46.2M | — | Filing → |
| WST | SELL | 2023-08-10 | $29.5M | — | Filing → |